Biosciences Stock Market Invest

Solid Biosciences Inc. (NASDAQ:SLDB) Receives $15.30 Average PT from Analysts Feb 19, 2025

Neurocrine Biosciences Price Target Adjusted by Royal Bank of Canada Feb 8, 2025

Analysts Set Target Price for Cogent Biosciences, Inc. at $14.83 Dec 23, 2024

Arcadia Biosciences RKDA Enters Analysts’ Spotlight Nov 14, 2023